167
Views
36
CrossRef citations to date
0
Altmetric
Review

Cancer stem cells – an old idea that’s new again: implications for the diagnosis and treatment of breast cancer

&
Pages 431-438 | Published online: 21 Mar 2007

Bibliography

  • SPRADLING A, DRUMMOND-BARBOSA D, KAI T: Stem cells find their niche. Nature (2001) 414(6859):98-104.
  • WATT FM, HOGAN BL: Out of Eden: stem cells and their niches. Science (2000) 287(5457):1427-1430.
  • WEISSMAN IL, COOPER MD: How the immune system develops. Sci. Am. (1993) 269(3):64-71.
  • LIN H: Stem cells: to be and not to be. Nature (2003) 425(6956):353-355.
  • MORRISON SJ, WANDYCZ AM, HEMMATI HD, WRIGHT DE, WEISSMAN IL: Identification of a lineage of multipotent hematopoietic progenitors. Development (1997) 124(10):1929-1939.
  • WEISSMAN IL, ANDERSON DJ, GAGE F: Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. (2001) 17:387-403.
  • HENNIGHAUSEN L, ROBINSON GW: Signaling pathways in mammary gland development. Dev. Cell (2001) 1(4):467-475.
  • RUDLAND PS, BARRACLOUGH R, FERNIG DG, SMITH JA: Growth and differentiation of the normal mammary gland and its tumours. Biochem. Soc. Symp. (1998) 63:1-20.
  • DEOME KB, FAULKIN LJ, JR., BERN HA, BLAIR PB: Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. (1959) 19(5):515-520.
  • DANIEL CW, YOUNG LJ, MEDINA D, DEOME KB: The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp. Gerontol. (1971) 6(1):95-101.
  • KORDON EC, SMITH GH: An entire functional mammary gland may comprise the progeny from a single cell. Development (1998) 125(10):1921-1930.
  • SMITH GH, CHEPKO G: Mammary epithelial stem cells. Microsc. Res. Tech. (2001) 52(2):190-203.
  • WELM BE, TEPERA SB, VENEZIA T, GRAUBERT TA, ROSEN JM, GOODELL MA: Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. (2002) 245(1):42-56.
  • GUDJONSSON T, VILLADSEN R, NIELSEN HL, RONNOV-JESSEN L, BISSELL MJ, PETERSEN OW: Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. (2002) 16(6):693-706.
  • STINGL J, EAVES CJ, KUUSK U, EMERMAN JT: Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation (1998) 63(4):201-213.
  • STINGL J, EAVES CJ, ZANDIEH I, EMERMAN JT: Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. (2001) 67(2):93-109.
  • DONTU G, ABDALLAH WM, FOLEY JM et al.: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. (2003) 17(10):1253-1270.
  • SHACKLETON M, VAILLANT F, SIMPSON KJ et al.: Generation of a functional mammary gland from a single stem cell. Nature (2006) 439(7072):84-88.
  • STINGL J, EIREW P, RICKETSON I et al.: Purification and unique properties of mammary epithelial stem cells. Nature (2006) 439(7079):993-997.
  • BONNET D, WARREN EH, GREENBERG PD, DICK JE, RIDDELL SR: CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc. Natl. Acad. Sci. USA (1999) 96(15):8639-8644.
  • HEMMATI HD, NAKANO I, LAZAREFF JA et al.: Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA (2003) 100(25):15178-15183.
  • SINGH SK, HAWKINS C, CLARKE ID et al.: Identification of human brain tumour initiating cells. Nature (2004) 432(7015):396-401.
  • SINGH SK, CLARKE ID, TERASAKI M et al.: Identification of a cancer stem cell in human brain tumors. Cancer Res. (2003) 63(18):5821-5828.
  • AL HAJJ M, WICHA MS, BENITO-HERNANDEZ A, MORRISON SJ, CLARKE MF: Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA (2003) 100(7):3983-3988.
  • LIU S, DONTU G, WICHA MS: Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. (2005) 7(3):86-95.
  • CLARKE RB: Ovarian steroids and the human breast: regulation of stem cells and cell proliferation. Maturitas (2006) 54(4):327-334.
  • TLSTY TD, CRAWFORD YG, HOLST CR et al.: Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J. Mammary Gland Biol. Neoplasia (2004) 9(3):263-274.
  • JACOBS JJ, KIEBOOM K, MARINO S, DEPINHO RA, VAN LOHUIZEN M: The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 397(6715):164-168.
  • NICKOLOFF BJ, OSBORNE BA, MIELE L: Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene (2003) 22(42):6598-6608.
  • MIELE L: Notch signaling. Clin. Cancer Res. (2006) 12:1074-1079.
  • MIELE L, GOLDE TE, OSBORNE BA: Notch signaling in cancer. Curr. Mol. Med. (2007) 6(8):905-918.
  • ARTAVANIS-TSAKONAS S, RAND MD, LAKE RJ: Notch signaling: cell fate control and signal integration in development. Science (1999) 284(5415):770-776.
  • DONTU G, JACKSON KW, MCNICHOLAS E, KAWAMURA MJ, ABDALLAH WM, WICHA MS: Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. (2004) 6(6):R605-R615.
  • CALLAHAN R, EGAN SE: Notch signaling in mammary development and oncogenesis. J. Mammary Gland Biol. Neoplasia (2004) 9(2):145-163.
  • DIEVART A, BEAULIEU N, JOLICOEUR P: Involvement of Notch1 in the development of mouse mammary tumors. Oncogene (1999) 18(44):5973-5981.
  • KIARIS H, POLITI K, GRIMM LM et al.: Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. Am. J. Pathol. (2004) 165(2):695-705.
  • KLINAKIS A, SZABOLCS M, POLITI K, KIARIS H, ARTAVANIS-TSAKONAS S, EFSTRATIADIS A: Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc. Natl. Acad. Sci. USA (2006) 103(24):9262-9267.
  • STYLIANOU S, CLARKE RB, BRENNAN K: Aberrant activation of notch signaling in human breast cancer. Cancer Res. (2006) 66(3):1517-1525.
  • REEDIJK M, ODORCIC S, CHANG L et al.: High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. (2005) 65(18):8530-8537.
  • BRENNAN KR, BROWN AM: Wnt proteins in mammary development and cancer. J. Mammary Gland Biol. Neoplasia (2004) 9(2):119-131.
  • HOWE LR, BROWN AM: Wnt signaling and breast cancer. Cancer Biol. Ther. (2004) 3(1):36-41.
  • MENIEL V, CLARKE AR: Wnt-cadherin connections in normal and neoplastic mammary epithelium. J. Mammary Gland Biol. Neoplasia (2003) 8(4):435-447.
  • LIU BY, MCDERMOTT SP, KHWAJA SS, ALEXANDER CM: The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. USA (2004) 101(12):4158-4163.
  • KATANO M: Hedgehog signaling pathway as a therapeutic target in breast cancer. Cancer Lett. (2005) 227(2):99-104.
  • LEWIS MT: Hedgehog signaling in mouse mammary gland development and neoplasia. J. Mammary Gland Biol. Neoplasia (2001) 6(1):53-66.
  • LEWIS MT, VELTMAAT JM: Next stop, the twilight zone: hedgehog network regulation of mammary gland development. J. Mammary Gland Biol. Neoplasia (2004) 9(2):165-181.
  • SORLIE T, TIBSHIRANI R, PARKER J et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA (2003) 100(14):8418-8423.
  • SORLIE T: Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur. J. Cancer (2004) 40(18):2667-2675.
  • DONTU G, EL ASHRY D, WICHA MS: Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol. Metab. (2004) 15(5):193-197.
  • HIRSCHMANN-JAX C, FOSTER AE, WULF GG, GOODELL MA, BRENNER MK: A distinct ‘side population’ of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle (2005) 4(2):203-205.
  • HIRSCHMANN-JAX C, FOSTER AE, WULF GG et al.: A distinct ‘side population’ of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA (2004) 101(39):14228-14233.
  • STAUD F, PAVEK P: Breast cancer resistance protein (BCRP/ABCG2). Int. J. Biochem. Cell Biol. (2005) 37(4):720-725.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.